Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management. (Q48557941)

12 February 2018

title

Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management. (English)

1 reference

12 February 2018

1 reference

Markus Luster

1

1 reference

12 February 2018

publication date

1 January 2006

1 reference

12 February 2018

published in

Acta Oncologica

1 reference

12 February 2018

volume

45

1 reference

12 February 2018

issue

8

1 reference

12 February 2018

page(s)

1018-1030

1 reference

12 February 2018

Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Compliance with follow-up and the informative value of diagnostic whole-body scan in patients with differentiated thyroid carcinoma given recombinant human TSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Near-lethal respiratory failure after recombinant human thyroid-stimulating hormone use in a patient with metastatic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: an indication for recombinant thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Malignant struma ovarii: an unusual presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Lack of efficacy of recombinant human thyrotropin versus thyroid hormone withdrawal for radioiodine therapy imaging in a patient with differentiated thyroid carcinoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Subcutaneous administration of recombinant human thyrotropin as an alternative to thyroid hormone withdrawal in patients with anticoagulated thyroid cancer: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600979013

10.1080/02841860600979013

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018